应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IVA Inventiva S.A.
交易中 07-17 14:50:13 EDT
3.27
-0.04
-1.26%
最高
3.27
最低
3.22
成交量
3,789
今开
3.22
昨收
3.31
日振幅
1.56%
总市值
4.55亿
流通市值
2.57亿
总股本
1.39亿
成交额
1.22万
换手率
0.00%
流通股本
7,851万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Inventiva Sa盘中异动 股价大跌6.07%报3.25美元
市场透视 · 07-15 16:39
Inventiva Sa盘中异动 股价大跌6.07%报3.25美元
Inventiva Sa盘中异动 股价大跌9.54%报3.13美元
市场透视 · 07-09
Inventiva Sa盘中异动 股价大跌9.54%报3.13美元
Inventiva Sa盘中异动 股价大涨6.31%
市场透视 · 07-07
Inventiva Sa盘中异动 股价大涨6.31%
Inventiva Sa盘中异动 临近收盘股价大跌6.58%
市场透视 · 07-01
Inventiva Sa盘中异动 临近收盘股价大跌6.58%
Inventiva Sa盘中异动 临近午盘股价大涨7.21%
市场透视 · 06-30
Inventiva Sa盘中异动 临近午盘股价大涨7.21%
Inventiva Sa盘中异动 快速拉升7.22%报3.29美元
市场透视 · 06-26
Inventiva Sa盘中异动 快速拉升7.22%报3.29美元
Inventiva Sa盘中异动 早盘大幅下跌5.00%报3.23美元
市场透视 · 06-24
Inventiva Sa盘中异动 早盘大幅下跌5.00%报3.23美元
Inventiva Sa盘中异动 快速下挫5.32%
市场透视 · 06-18
Inventiva Sa盘中异动 快速下挫5.32%
Inventiva Sa盘中异动 早盘急速拉升5.87%报3.56美元
市场透视 · 06-17
Inventiva Sa盘中异动 早盘急速拉升5.87%报3.56美元
Inventiva Sa盘中异动 早盘大幅下跌5.00%报3.30美元
市场透视 · 06-16
Inventiva Sa盘中异动 早盘大幅下跌5.00%报3.30美元
Inventiva Sa盘中异动 下午盘快速下挫5.44%
市场透视 · 06-11
Inventiva Sa盘中异动 下午盘快速下挫5.44%
Inventiva Sa盘中异动 急速下挫6.01%报3.40美元
市场透视 · 06-10
Inventiva Sa盘中异动 急速下挫6.01%报3.40美元
Inventiva Sa盘中异动 临近午盘股价大涨6.06%报3.82美元
市场透视 · 06-09
Inventiva Sa盘中异动 临近午盘股价大涨6.06%报3.82美元
Inventiva Sa盘中异动 股价大涨7.33%报3.66美元
市场透视 · 06-06
Inventiva Sa盘中异动 股价大涨7.33%报3.66美元
Inventiva Sa盘中异动 大幅下挫6.63%报3.38美元
市场透视 · 06-04
Inventiva Sa盘中异动 大幅下挫6.63%报3.38美元
Inventiva Sa盘中异动 股价大跌7.55%
市场透视 · 06-02
Inventiva Sa盘中异动 股价大跌7.55%
Inventiva Sa盘中异动 快速上涨7.05%报3.31美元
市场透视 · 05-27
Inventiva Sa盘中异动 快速上涨7.05%报3.31美元
Inventiva Sa盘中异动 早盘股价大跌6.63%
市场透视 · 05-21
Inventiva Sa盘中异动 早盘股价大跌6.63%
Inventiva Sa盘中异动 股价大涨5.08%报3.31美元
市场透视 · 05-20
Inventiva Sa盘中异动 股价大涨5.08%报3.31美元
Inventiva Sa盘中异动 早盘股价大跌6.23%报3.16美元
市场透视 · 05-16
Inventiva Sa盘中异动 早盘股价大跌6.23%报3.16美元
加载更多
公司概况
公司名称:
Inventiva S.A.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Inventiva S.A.成立于2011年,并于2016年注册成立。该公司是一家临床阶段的生物制药公司,致力于开发口服小分子疗法,以治疗非酒精性脂肪性肝炎或NASH,粘多糖酶或MPS以及其他未满足医疗需求的严重疾病。该公司建立了一个由发现引擎支持的管道,该发现引擎具有广泛的专有分子库,一个全资研发设施以及一个在开发针对核受体,转录因子和表观遗传调控的化合物方面拥有丰富专业知识和经验的团队。
发行价格:
--
{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":3.2694,"timestamp":1752777053887,"preClose":3.311,"halted":0,"volume":3789,"delay":0,"floatShares":78514774,"shares":139105820,"eps":-3.190356,"marketStatus":"交易中","change":-0.0416,"latestTime":"07-17 14:50:13 EDT","open":3.2177,"high":3.2694,"low":3.2177,"amount":12210.4901295,"amplitude":0.015615,"askPrice":3.36,"askSize":100,"bidPrice":3.2,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-3.190356,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752782400000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1594353600000,"exchange":"NASDAQ","adjPreClose":3.311,"volumeRatio":0.496758},"requestUrl":"/m/hq/s/IVA","defaultTab":"news","newsList":[{"id":"2551831199","title":"Inventiva Sa盘中异动 股价大跌6.07%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551831199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551831199?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:39","pubTimestamp":1752597547,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日00时39分,Inventiva Sa股票出现异动,股价急速跳水6.07%。截至发稿,该股报3.25美元/股,成交量3109股,换手率0.00%,振幅2.31%。Inventiva Sa股票所在的生物技术行业中,整体跌幅为1.02%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716003908a44cd06b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716003908a44cd06b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2550652860","title":"Inventiva Sa盘中异动 股价大跌9.54%报3.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550652860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550652860?lang=zh_cn&edition=full","pubTime":"2025-07-10 00:15","pubTimestamp":1752077708,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日00时15分,Inventiva Sa股票出现异动,股价快速下挫9.54%。截至发稿,该股报3.13美元/股,成交量1.2796万股,换手率0.01%,振幅3.86%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为1.10%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710001508a69fc6ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710001508a69fc6ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2549476559","title":"Inventiva Sa盘中异动 股价大涨6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549476559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549476559?lang=zh_cn&edition=full","pubTime":"2025-07-08 00:08","pubTimestamp":1751904521,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日00时08分,Inventiva Sa股票出现异动,股价急速上涨6.31%。截至发稿,该股报3.20美元/股,成交量8864股,换手率0.01%,振幅6.31%。Inventiva Sa股票所在的生物技术行业中,整体跌幅为0.53%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708000842979d37d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708000842979d37d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2548882172","title":"Inventiva Sa盘中异动 临近收盘股价大跌6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548882172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548882172?lang=zh_cn&edition=full","pubTime":"2025-07-02 04:00","pubTimestamp":1751400036,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日04时00分,Inventiva Sa股票出现异动,股价急速下跌6.58%。截至发稿,该股报2.98美元/股,成交量2492股,换手率0.00%,振幅1.57%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.43%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020400369532f302&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020400369532f302&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2547015700","title":"Inventiva Sa盘中异动 临近午盘股价大涨7.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547015700?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:34","pubTimestamp":1751297665,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日23时34分,Inventiva Sa股票出现波动,股价大幅拉升7.21%。截至发稿,该股报3.27美元/股,成交量384股,换手率0.00%,振幅0.00%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.68%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233425a4c6f624&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233425a4c6f624&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2546737678","title":"Inventiva Sa盘中异动 快速拉升7.22%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546737678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546737678?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:07","pubTimestamp":1750950464,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日23时07分,Inventiva Sa股票出现异动,股价急速上涨7.22%。截至发稿,该股报3.29美元/股,成交量9604股,换手率0.01%,振幅4.61%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.26%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626230744a71f1b59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626230744a71f1b59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2545233717","title":"Inventiva Sa盘中异动 早盘大幅下跌5.00%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545233717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545233717?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:58","pubTimestamp":1750773528,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时58分,Inventiva Sa股票出现波动,股价大幅下跌5.00%。截至发稿,该股报3.23美元/股,成交量103股,换手率0.00%,振幅0.00%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.74%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624215848a4bb9ffd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624215848a4bb9ffd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2544904285","title":"Inventiva Sa盘中异动 快速下挫5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544904285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544904285?lang=zh_cn&edition=full","pubTime":"2025-06-19 01:09","pubTimestamp":1750266545,"startTime":"0","endTime":"0","summary":"北京时间2025年06月19日01时09分,Inventiva Sa股票出现异动,股价大幅下挫5.32%。截至发稿,该股报3.25美元/股,成交量4637股,换手率0.00%,振幅3.20%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.49%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619010906a4b0ef3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619010906a4b0ef3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2544649999","title":"Inventiva Sa盘中异动 早盘急速拉升5.87%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544649999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544649999?lang=zh_cn&edition=full","pubTime":"2025-06-17 23:34","pubTimestamp":1750174479,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日23时34分,Inventiva Sa股票出现波动,股价快速拉升5.87%。截至发稿,该股报3.56美元/股,成交量463股,换手率0.00%,振幅1.19%。Inventiva Sa股票所在的生物技术行业中,整体跌幅为0.91%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617233440a70e9fe9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617233440a70e9fe9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2543051756","title":"Inventiva Sa盘中异动 早盘大幅下跌5.00%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543051756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543051756?lang=zh_cn&edition=full","pubTime":"2025-06-16 22:21","pubTimestamp":1750083705,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日22时21分,Inventiva Sa股票出现异动,股价快速跳水5.00%。截至发稿,该股报3.30美元/股,成交量1923股,换手率0.00%,振幅1.44%。Inventiva Sa股票所在的生物技术行业中,整体跌幅为0.19%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616222146951ecec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616222146951ecec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2542799534","title":"Inventiva Sa盘中异动 下午盘快速下挫5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542799534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542799534?lang=zh_cn&edition=full","pubTime":"2025-06-12 02:52","pubTimestamp":1749667961,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日02时52分,Inventiva Sa股票出现波动,股价快速跳水5.44%。截至发稿,该股报3.45美元/股,成交量4725股,换手率0.00%,振幅2.19%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.22%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612025242a70407d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612025242a70407d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2542344623","title":"Inventiva Sa盘中异动 急速下挫6.01%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542344623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542344623?lang=zh_cn&edition=full","pubTime":"2025-06-11 01:52","pubTimestamp":1749577963,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日01时52分,Inventiva Sa股票出现波动,股价急速下挫6.01%。截至发稿,该股报3.40美元/股,成交量6343股,换手率0.00%,振幅5.02%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为1.12%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506110152449779b107&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506110152449779b107&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2542544336","title":"Inventiva Sa盘中异动 临近午盘股价大涨6.06%报3.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542544336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542544336?lang=zh_cn&edition=full","pubTime":"2025-06-09 23:33","pubTimestamp":1749483219,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日23时33分,Inventiva Sa股票出现波动,股价急速上涨6.06%。截至发稿,该股报3.82美元/股,成交量6.3795万股,换手率0.05%,振幅5.71%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.88%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609233339a700d077&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609233339a700d077&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2541653418","title":"Inventiva Sa盘中异动 股价大涨7.33%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541653418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541653418?lang=zh_cn&edition=full","pubTime":"2025-06-06 22:02","pubTimestamp":1749218541,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时02分,Inventiva Sa股票出现波动,股价快速上涨7.33%。截至发稿,该股报3.66美元/股,成交量3.1616万股,换手率0.02%,振幅9.97%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为1.10%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506062202219511723b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506062202219511723b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2541096930","title":"Inventiva Sa盘中异动 大幅下挫6.63%报3.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541096930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541096930?lang=zh_cn&edition=full","pubTime":"2025-06-05 03:58","pubTimestamp":1749067102,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日03时58分,Inventiva Sa股票出现波动,股价大幅跳水6.63%。截至发稿,该股报3.38美元/股,成交量2690股,换手率0.00%,振幅3.86%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.09%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605035822950eee4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605035822950eee4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2540796210","title":"Inventiva Sa盘中异动 股价大跌7.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540796210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540796210?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:06","pubTimestamp":1748873180,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时06分,Inventiva Sa股票出现波动,股价快速下挫7.55%。截至发稿,该股报3.13美元/股,成交量2087股,换手率0.00%,振幅0.00%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.00%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602220620976e87c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602220620976e87c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2538622954","title":"Inventiva Sa盘中异动 快速上涨7.05%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538622954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538622954?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:56","pubTimestamp":1748354175,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时56分,Inventiva Sa股票出现异动,股价快速拉升7.05%。截至发稿,该股报3.31美元/股,成交量214股,换手率0.00%,振幅0.00%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.97%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527215615a6ef09f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527215615a6ef09f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2537252939","title":"Inventiva Sa盘中异动 早盘股价大跌6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537252939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537252939?lang=zh_cn&edition=full","pubTime":"2025-05-21 22:05","pubTimestamp":1747836335,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日22时05分,Inventiva Sa股票出现异动,股价快速下挫6.63%。Inventiva Sa股票所在的生物技术行业中,整体跌幅为0.29%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505212205359760e1cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505212205359760e1cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2537644800","title":"Inventiva Sa盘中异动 股价大涨5.08%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537644800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537644800?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:47","pubTimestamp":1747756074,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时47分,Inventiva Sa股票出现波动,股价大幅上涨5.08%。截至发稿,该股报3.31美元/股,成交量4676股,换手率0.00%,振幅5.56%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.35%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520234754a4859bab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520234754a4859bab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4082","IVA","NRXS"],"gpt_icon":0},{"id":"2535312504","title":"Inventiva Sa盘中异动 早盘股价大跌6.23%报3.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535312504","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535312504?lang=zh_cn&edition=full","pubTime":"2025-05-16 23:02","pubTimestamp":1747407750,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日23时02分,Inventiva Sa股票出现异动,股价大幅下跌6.23%。截至发稿,该股报3.16美元/股,成交量1603股,换手率0.00%,振幅3.26%。Inventiva Sa股票所在的生物技术行业中,整体涨幅为0.37%。Inventiva Sa公司简介:Inventiva SA 是一家总部位于法国的生物制药公司,专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor,用于治疗非酒精性脂肪性肝炎或 NASH 患者,这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516230230975be815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516230230975be815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://inventivapharma.com","stockEarnings":[{"period":"1week","weight":-0.0161},{"period":"1month","weight":-0.0126},{"period":"3month","weight":-0.0119},{"period":"6month","weight":0.537},{"period":"1year","weight":0.2769},{"period":"ytd","weight":0.5514}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.0357},{"period":"3month","weight":0.1858},{"period":"6month","weight":0.0446},{"period":"1year","weight":0.1051},{"period":"ytd","weight":0.0651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inventiva S.A.成立于2011年,并于2016年注册成立。该公司是一家临床阶段的生物制药公司,致力于开发口服小分子疗法,以治疗非酒精性脂肪性肝炎或NASH,粘多糖酶或MPS以及其他未满足医疗需求的严重疾病。该公司建立了一个由发现引擎支持的管道,该发现引擎具有广泛的专有分子库,一个全资研发设施以及一个在开发针对核受体,转录因子和表观遗传调控的化合物方面拥有丰富专业知识和经验的团队。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.0537},{"month":2,"riseRate":0.6,"avgChangeRate":0.041998},{"month":3,"riseRate":0,"avgChangeRate":-0.105896},{"month":4,"riseRate":0.2,"avgChangeRate":-0.08167},{"month":5,"riseRate":0.6,"avgChangeRate":0.107821},{"month":6,"riseRate":0.2,"avgChangeRate":-0.118686},{"month":7,"riseRate":0.4,"avgChangeRate":-0.069906},{"month":8,"riseRate":0.2,"avgChangeRate":0.009571},{"month":9,"riseRate":0.4,"avgChangeRate":-0.030876},{"month":10,"riseRate":0.8,"avgChangeRate":0.137564},{"month":11,"riseRate":0.2,"avgChangeRate":-0.027915},{"month":12,"riseRate":0.8,"avgChangeRate":0.022186}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}